glp-1 study news With the surging popularity of medications for weight loss, many telehealth providers are now offering quick and easy access to these drugs without insurance coverage. In fact, a recent Yale January 2026: New or Expanded

The semaglutide arm activates the GLP-1 receptor an incretin receptor expressed in the pancreas, gut and brain enhancing glucose-dependent insulin secretion, slowing gastric emptying and signaling satiety in hypothalamic appetite centers

Overall, patients whose tumors had more of these receptors were about one-third less likely to die during the study period

What are some of the boxes that we should check off that we're not missing certain medical conditions

Reconstituting a full 30mL vial provides convenience but subjects the entire volume to 28 days of oxidative exposure even under perfect refrigeration, the final doses in week four have lost 1015% potency compared to week one

In September 2025, the agency issued over 50 warning letters to companies selling GLP-1 products (including retatrutide) with marketing that implied human use

Do not use the product in case of circulatory system problems or sensitivity to caffeine